GLENVIEW CAPITAL MANAGEMENT, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1138995
NEW YORK, NY
Position in TMO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$123,140,553
-$6,625,536 QoQ
Shares Held
250,525
+11.9% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
3.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026GLENVIEW CAPITAL MANAGEMENT, LLC holds $177,124,194 across 3 Diagnostics & Research names. TMO ranks #1 (69.5% of the industry book) .
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $123,140,553 | 250,525 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $129,766,089 | 223,947 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $137,232,043 | 282,941 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,546,000 | 100,000 | Shares | Sole | 2025-08-14 | |
| 2020-06-30 | $29,550,638 | 81,555 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||